Almac has invested £13 million into two cancer research ventures, with £7 million to be spent in Northern Ireland.
The pharmaceutical company, in a partnership with Queen’s University, are set to undertake research into the clinical performance of a drug developed within Northern Ireland. There will also be a project that has the intention of setting up a drug discovery unit in Queen’s Cancer research and Cell Biology centre at Belfast City Hospital.
Almac is an international organisation providing a comprehensive range of services from research through pharmaceutical development to commercialisation of product. For more information on Almac’s services and the company itself, click here.